Celyad announces new agreements with Celdara Medical and Dartmouth College

Celyad announces new agreements with Celdara Medical and Dartmouth College

Information on the total number of voting rights and shares (Articles 15 of the Law of 2 May 2007)

Information on the total number of voting rights and shares (Articles 15 of the Law of 2 May 2007)

Celyad announces initiation of the SHRINK trial

Celyad announces initiation of the SHRINK trial

Celyad publishes additional pre-clinical data in support of THINK trial

Celyad publishes additional pre-clinical data in support of THINK trial

Discover our news

Upcoming events

Aug 21-25, 2017

Bioprocessing summit

Sep 19-21, 2017

Phacilitate Europe

Discover all events

Press contacts

Celyad

Nicolas Van Hoecke
Director, Investor Relations & Communications

+32 (0)10 39 41 84

Stern Investor Relations (US)

Will O’Connor, Michael Schaffzin

+1 212 362 1200

Consilium Strategic Communications (UK)

Chris Welsh, Chris Gardner

+44 20 3709 5700

NewCap (France)

Nicolas Merigeau, Pierre Laurent

+ 33(0)1 44 71 94 94

Comfi (Belgium)

Gunther De Backer, Sabine Leclercq

+32(0) 2 290 90 91